SecBot SecBot
6-K ·Filed Nov 4, 2026

IMCC

IM Cannabis Corp.
BEARISH
Impact 6/10
Horizonweeks Processed12d 23h ago SEC0001178913-26-005019
Notable filing: 6-K
Actionable Insight ▼ Bearish

Monitor the company's ability to service the note and the potential for further dilution if the conversion price drops toward the $0.1449 floor. The registration statement filing obligation within 30 trading days will determine when the investor can resell shares.

DirectionBearish
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+5
Entry
$0.5934
T+0 close · Nov 4, 2026 · via day close
Latest settled
−6.81%
T+5 · $0.5530 · next T+20 in 17d
Vs SPY
−10.10%
α at T+5
Latest observation
−7.88%
T+6 · FF3 residual α
  1. T+0 · Nov 5 $0.5934entry
  2. T+1 · 11d ago +7.52%α +7.20% · $0.6380
  3. T+5 · 5d ago −6.81%α −10.10% · $0.5530
  4. T+7 · todayOpen
  5. T+20 · in 17d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

IM Cannabis Corp. closed a $1.2M convertible note financing with an institutional investor, issuing a convertible promissory note with a 15% OID and a warrant for 3,936,330 shares at $0.610. Net proceeds of $1.02M will be used for general corporate purposes. The financing is highly dilutive given the company's $1M market cap and the conversion price floor of $0.1449.

Key Facts

  • Convertible note principal amount of $1,200,000 with 15% original issue discount, net proceeds $1,020,000
  • Warrant to purchase up to 3,936,330 common shares at $0.610 per share, exercisable immediately through November 3, 2029
  • Conversion price is lower of fixed $0.610 or 85% of lowest 20-day VWAP, with a floor of $0.1449
  • Market cap is approximately $1M; the warrant alone represents potential dilution of 3.9M+ shares against a tiny base
  • Note matures in 28 months, repayable in 10 equal monthly installments starting after month 18
  • Company may request additional notes up to $1.2M per quarter starting January 2027

Financial Impact

Net proceeds of $1.02M, representing over 100% of the company's $1M market cap; warrant shares equal to ~3.9M shares with no stated outstanding share count but market cap implies extreme dilution

dilutiondebtcash

Risk Factors

  • Extreme dilution risk: warrant alone covers 3.9M shares vs a $1M market cap, and the note conversion could add further shares at deeply discounted prices
  • Non-recourse structure means the company's only repayment obligation is through the warrant and conversion, if the stock price falls, the investor may convert at the floor price, massively diluting existing holders
  • Company may draw additional $1.2M per quarter starting January 2027, compounding dilution
  • Israeli regulatory risk: beneficial ownership above 4.99% requires IMCA approval, and failure could impact subsidiary licenses

Market Snapshot

Exchange
Nasdaq
Sector
Medicinal Chemicals & Botanical Products
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Documents Analyzed

This report is based on 9 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001178913-26-005019
Exhibit: exhibit_10-1.htm0001178913-26-005019
Exhibit: exhibit_4-1.htm0001178913-26-005019
Exhibit: exhibit_99-1.htm0001178913-26-005019
Document: zk2636339.htm0001178913-26-005019
Document: 0001178913-26-005019-index-headers.html0001178913-26-005019
Document: 0001178913-26-005019-index.html0001178913-26-005019
Document: 0001178913-26-005019.txt0001178913-26-005019
Earnings Context (Synthetic; results releases only)0001178913-26-005019

Track record

23 reports on IMCC

Performance horizon

9 of 9 bullish or bearish reports moved the stock their way by T+20. Best: +82.97% at T+60 after the Aug 13, 2026 report. 10 of 10 went positive at some point.

Filters
  1. Nov 17, 2026today SC 13G Neutral 4/10 Entry $0.4995 Now $0.4800 −3.90% settles Dec 16
  2. Nov 13, 20263d ago 6-K Bearish 6/10 Entry price pending
  3. Nov 13, 20263d ago Press Release Bearish 6/10 Entry $0.5750 Now $0.4800 +16.52% settles Dec 15
  4. Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $0.5800 Now $0.4800 −17.24% settles Dec 15
  5. Nov 4, 202612d ago 6-K Bearish 6/10 Viewing Entry $0.5934 Now $0.4800 +19.11% settles Dec 4
  6. Nov 4, 202612d ago Press Release Bearish 5/10 Entry $0.5934 Now $0.4800 +19.11% settles Dec 4
  7. Oct 21, 202627d ago EFFECT Neutral 4/10 Entry $1.19 Now $0.4800 −59.66% settles Nov 18
  8. Oct 2, 20266w ago 6-K Mixed 6/10 Entry $1.94 to $0.7675 Now $0.4800 −75.26% ▼ −60.44% −57.86% vs SPY
  9. Sep 25, 20267w ago 6-K Bearish 6/10 Entry $2.48 to $0.8400 Now $0.4800 +80.65% ▲ +66.13% +66.10% vs SPY
  10. Sep 24, 20267w ago 424B5 Bearish 7/10 Entry $3.18 to $0.9250 Now $0.4800 +84.91% ▲ +70.91% +70.49% vs SPY
Showing 10 of 23

US Market Status

Market Open · Closes in 18m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 4, 2026